WASHINGTON— The Society for Cardiovascular Angiography and Interventions (SCAI) has selected Samantha Espinosa, MD, MPH, as the recipient of the 2025–26 SCAI Women in Innovations (WIN) Complex and ...

The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) have published the first rigorous, evidence-based, multisociety recommendations to guide the use of ...

A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to action for managing cardiogenic shock (CS), establishing lactate clearance ...

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime ...

Get the latest news and updates from TCTMD. Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research ...

Windtree Therapeutics, Inc. announced that it is preparing for an interim analysis of its SEISMiC C Phase 2 study of istaroxime, targeting results for July 2025. This global, placebo-controlled, ...